April 08, 2019
1 min watch
Save

VIDEO: Early clinical results with Oxervate for neurotrophic keratitis promising

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SCOTTSDALE, Ariz. — At Cornea360, Kenneth A. Beckman, MD, discusses his early, promising clinical results with Oxervate (cenegermin-bkbj 0.002% ophthalmic solution, Dompé) for the treatment of neurotrophic keratitis.